Screener
Eligibility screening
89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma
1 US site in TX
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.